NDC 13107-073 – Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Dextroamphetamine Saccharate 5 mg/1; Amphetamine Aspartate Monohydrate 5 mg/1; Dextroamphetamine Sulfate 5 mg/1; Amphetamine Sulfate 5 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII 1 recall

Product NDC13107-073

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Labeler
Aurolife Pharma, LLC
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA202424
Marketed since
November 27, 2013
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate →

Package NDC codes (5)

Package NDCDescriptionSince
13107-073-01100 TABLET in 1 BOTTLE (13107-073-01)Nov 27, 2013
13107-073-05500 TABLET in 1 BOTTLE (13107-073-05)Nov 27, 2013
13107-073-25250 TABLET in 1 BOTTLE (13107-073-25)Nov 27, 2013
13107-073-5050 TABLET in 1 BOTTLE (13107-073-50)Nov 27, 2013
13107-073-991000 TABLET in 1 BOTTLE (13107-073-99)Nov 27, 2013

Recalls mentioning this NDC

Other Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate products